Buttyan R - Search Results

1

Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers.

Buttyan R, Sawczuk IS, Benson MC, Siegal JD, Olsson CA. Buttyan R, et al. Prostate. 1987;11(4):327-37. doi: 10.1002/pros.2990110405. Prostate. 1987. PMID: 2446300

2

Immediate induction of c-fos and c-myc transcripts following unilateral nephrectomy.

Sawczuk IS, Olsson CA, Hoke G, Buttyan R. Sawczuk IS, et al. Among authors: buttyan r. Nephron. 1990;55(2):193-5. doi: 10.1159/000185951. Nephron. 1990. PMID: 2113996

3

Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death.

Connor J, Sawczuk IS, Benson MC, Tomashefsky P, O'Toole KM, Olsson CA, Buttyan R. Connor J, et al. Among authors: buttyan r. Prostate. 1988;13(2):119-30. doi: 10.1002/pros.2990130204. Prostate. 1988. PMID: 3140224

4

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay.

Katz AE, Olsson CA, Raffo AJ, Cama C, Perlman H, Seaman E, O'Toole KM, McMahon D, Benson MC, Buttyan R. Katz AE, et al. Among authors: buttyan r. Urology. 1994 Jun;43(6):765-75. doi: 10.1016/0090-4295(94)90132-5. Urology. 1994. PMID: 7515202

5

Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen.

Cama C, Olsson CA, Raffo AJ, Perlman H, Buttyan R, O'Toole K, McMahon D, Benson MC, Katz AE. Cama C, et al. Among authors: buttyan r. J Urol. 1995 May;153(5):1373-8. J Urol. 1995. PMID: 7536252 Free article.

6

Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R. Colombel M, et al. Among authors: buttyan r. Am J Pathol. 1993 Aug;143(2):390-400. Am J Pathol. 1993. PMID: 7688182 Free PMC article.

7

Abnormal prostate development in C3(1)-bcl-2 transgenic mice.

Zhang X, Chen MW, Ng A, Ng PY, Lee C, Rubin M, Olsson CA, Buttyan R. Zhang X, et al. Among authors: buttyan r. Prostate. 1997 Jun 15;32(1):16-26. doi: 10.1002/(sici)1097-0045(19970615)32:1<16::aid-pros3>3.0.co;2-a. Prostate. 1997. PMID: 9207953

8

Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer.

Dorai T, Olsson CA, Katz AE, Buttyan R. Dorai T, et al. Among authors: buttyan r. Prostate. 1997 Sep 1;32(4):246-58. doi: 10.1002/(sici)1097-0045(19970901)32:4<246::aid-pros4>3.0.co;2-h. Prostate. 1997. PMID: 9288183

9

Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells.

Ghafar MA, Anastasiadis AG, Chen MW, Burchardt M, Olsson LE, Xie H, Benson MC, Buttyan R. Ghafar MA, et al. Among authors: buttyan r. Prostate. 2003 Jan 1;54(1):58-67. doi: 10.1002/pros.10162. Prostate. 2003. PMID: 12481256

10

Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy.

Olsson CA, de Vries GM, Raffo AJ, Benson MC, O'Toole K, Cao Y, Buttyan RE, Katz AE. Olsson CA, et al. Among authors: buttyan re. J Urol. 1996 May;155(5):1557-62. J Urol. 1996. PMID: 8627821 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters